Sign Up to like & get
recommendations!
2
Published in 2023 at "Nucleic acids research"
DOI: 10.1093/nar/gkad212
Abstract: The deubiquitinating enzyme Ataxin-3 (ATXN3) contains a polyglutamine (PolyQ) region, the expansion of which causes spinocerebellar ataxia type-3 (SCA3). ATXN3 has multiple functions, such as regulating transcription or controlling genomic stability after DNA damage. Here…
read more here.
Keywords:
atxn3;
transcription;
chromatin;
atxn3 controls ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Molecules and Cells"
DOI: 10.14348/molcells.2022.0104
Abstract: For proper function of proteins, their subcellular localization needs to be monitored and regulated in response to the changes in cellular demands. In this regard, dysregulation in the nucleocytoplasmic transport (NCT) of proteins is closely…
read more here.
Keywords:
atxn3;
nucleocytoplasmic transport;
nct atxn3;
atxn3 proteins ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Frontiers in Neuroscience"
DOI: 10.3389/fnins.2022.1112688
Abstract: Spinocerebellar Ataxia Type 3 (SCA3) is a member of the family of polyglutamine (polyQ) diseases that are caused by anomalous CAG triplet repeat expansions in several genes. SCA3 results from abnormal polyQ expansion in the…
read more here.
Keywords:
atxn3;
ubiquitin binding;
toxicity;
ataxia type ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Frontiers in Molecular Neuroscience"
DOI: 10.3389/fnmol.2023.1154203
Abstract: Spinocerebellar ataxia type 3 (SCA3), also known as Machado–Joseph disease, is the most common dominantly inherited ataxia. SCA3 is caused by a CAG repeat expansion in the ATXN3 gene that encodes an expanded tract of…
read more here.
Keywords:
atxn3;
k63;
age dependent;
spinocerebellar ataxia ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10020370
Abstract: The atypical antipsychotic aripiprazole is a Food and Drug Administration-approved drug for the treatment of psychotic, mood, and other psychiatric disorders. Previous drug discovery efforts pinpointed aripiprazole as an effective suppressor of Machado–Joseph disease (MJD)…
read more here.
Keywords:
atxn3;
serotonin;
motor dysfunction;
mutant atxn3 ... See more keywords